This week's roundup of Houston innovators includes Nicole Rogers of Validere, Allie Danziger of Ampersand, and Ashley Small of Medley Inc. Courtesy photos

Editor's note: In the week's roundup of Houston innovators to know, I'm introducing you to three female innovators across industries — from energy tech to business entrepreneurship.

Nicole Rogers, senior vice president at Validere

Nicole Rogers, senior vice president at Validere, joins the Houston Innovators Podcast to discuss how her company has grown exponentially over the past year. Photo courtesy of Validere

Nicole Rogers joined Canadian startup Validere during the summer last year — right smack dab in the middle of a pandemic. But despite COVID-19 and the drop in oil prices, the energy company grew exponentially — in clientbase, in venture capital support, and in employee count.

"One of the things we found that was to our advantage throughout the pandemic was a lot of folks in oil were having a career identity crisis. Oil really struggles with employment elasticity," Rogers says. "A lot of the colleagues we were talking to were just fatigued with the ups and downs going on in the past decade."

Rogers, who's based in the company's Houston office, shares more about Validere's growth and opportunities in the new year — plus what she thinks Houston needs to do to maintain its status of energy capital of the world in the episode. Click here to read more and to stream the podcast.

Allie Danziger, founder of Ampersand

Houston entrepreneur, Allie Danziger, wanted to create a program for young professionals looking to gain experience in unprecedented times. Photo courtesy of Ampersand

Allie Danziger has two small children, but she started thinking about if her kids were college age, would she want them to enroll in a virtual college experience or hold off for a time where they could have a more traditional experience. Realizing she probably wasn't alone, she thought about how she could create an alternative for high school grads — in this time of the pandemic but also in a time where college degrees aren't the best option for job security.

"I really believe that it scales way beyond this pandemic," says Danziger. In her research, she saw a lack of career-focused gap curriculums and resources available. "There are no programs that help you determine what the right path for you is—to really do that self-exploration and then apply it to your career path," she explains. Click here to read more.

Ashley Small, founder and CEO of Medley Inc.

From events to online shopping — here are four tech trends to look out for this year according to Ashley Small. Photo courtesy of Medley

It's a new year and the perfect time to reflect on where society is at from a technological standpoint. In light of the pandemic and an overarching trend of tapping into tech to provide solutions to COVID-19-related challenges, 2021 will likely see more of these trends.

"As a business owner, it's clear to me that many of these shifts will persist long after the pandemic has ended," writes Ashley Small, founder and CEO of Medley Inc., in a guest column for InnovationMap.

From subscriptions to online shopping, Small highlighted the types of tech in the digital realm that deserve our special attention in 2021. Click here to read more.

Nicole Rogers, senior vice president at Validere, joins the Houston Innovators Podcast to discuss how her company has grown exponentially over the past year. Photo courtesy of Validere

Canadian energy tech startup doubles down on Houston and plans to scale

HOUSTON INNOVATORS PODCAST EPISODE 65

While the pandemic and last year's drop in oil prices may have caused their own set of challenges, at least one energy tech startup saw plenty of opportunity for growth amid the unprecedented times.

In 2020, Validere, which is based in Calgary and has a growing office in Houston, closed a $15 million series A round with participation from two Silicon Valley firms — Greylock and Wing Venture Capital — as well as doubled their employee base. The company has software and hardware supplychain solutions for oil and gas companies that improves visibility and trust in oil testing.

"We came out of our Q2 and Q3 having the best quarters that the company had ever had," says Nicole Rogers, senior vice president at Validere, on this week's episode of the Houston Innovators Podcast. "Many of our results were tied to our customers being forced to do something differently. When you can't earn your profits the same way you did before, you will constantly look for profits somewhere else — and we are core to that movement."

Hiring for startups is always a challenge — especially competing with both big tech and big oil companies — but Rogers says this is another example of how both the instability in oil and gas coupled with COVID-19-caused crisis played to their benefit.

"One of the things we found that was to our advantage throughout the pandemic was a lot of folks in oil were having a career identity crisis. Oil really struggles with employment elasticity," Rogers says. "A lot of the colleagues we were talking to were just fatigued with the ups and downs going on in the past decade."

Validere's technology is also beneficial to oil and gas companies who are looking to use data and supply chain optimization increase transparency in a market that is prioritizing sustainability and ESG — Environmental, Social, and Corporate Governance.

"ESG is a supply chain problem and opportunity — and that's what we do at Validere," Rogers says. "We're transforming the world's largest supply chains through the use of software, machine learning, artificial intelligence, and our staff."

Rogers, who's based in the company's Houston office, shares more about Validere's growth and opportunities in the new year — plus what she thinks Houston needs to do to maintain its status of energy capital of the world in the episode. Listen to the full interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston cleantech, space startups named to World Economic Forum cohort

top honor

Two Houston-based startups have been selected to join the World Economic Forum's Technology Pioneers community.

The two-year program aims to help mission-driven, early-stage start-ups scale their innovations through multi-stakeholder initiatives, co-creating partnerships and other gatherings for community members. One-hundred startups are selected each year from around the globe, this year hailing from 23 countries and working in AI, energy, space, biotech markets and more.

Cleantech startup Vaulted Deep was one of 11 energy and climate companies to be named to the cohort. Julia Reichelstein and Omar Abou-Sayed founded the company in 2023. Its technology injects excess organic waste underground to remove carbon dioxide from the atmosphere.

Last year, Vaulted Deep inked a 12-year deal with Microsoft to remove up to 4.9 million metric tons of carbon dioxide from the environment.

The startup has earned several accolades in recent years, including a No. 3 spot on Fast Company’s list of the World’s Most Innovative Companies of 2026. It was also recently named to market intelligence and advisory firm Cleantech Group's annual Global Cleantech 100 list for a second year in a row.

"Waste management is one of the world's great invisible infrastructure systems ... The need for new infrastructure is growing as disposal challenges become more complex and regulations evolve. Vaulted is building the first new disposal pathway for organic waste in decades by putting it deep underground, permanently," the company shared in a LinkedIn post. "This year, we're joining the World Economic Forum's 2026 Tech Pioneers alongside innovators working on the many interconnected challenges shaping our future."

Houston-based Venus Aerospace was also selected to join the cohort, along with six other spacetech companies. The company was founded in 2020 by Sassie and Andrew Duggleby.

The startup specializes in next-generation rocket engine propulsion as a cleaner alternative to traditional combustion engines. The company's rotating detonation rocket engine (RDRE) burns fuel more efficiently and completed a successful high-thrust test flight last year. Venus says it’s the only company in the world that makes a flight-proven, high-thrust RDRE with a “clear path to scaled production.”

"Frontier technologies matter most when they expand what people, industries, and nations can do," Sassie Duggleby, co-founder and CEO of Venus, said in a news release. "For Venus, RDRE does not just represent a more efficient engine. It is a foundation for faster movement, more capable space systems, and new forms of connectivity across the planet. Being named a Technology Pioneer validates the potential of this technology to help shape a future where distance is less limiting."

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston Methodist receives record $110M gift, names future tower

historic gift

Houston Methodist has received the largest gift in the health system's history to establish new funds for neurological, neuroscience, and women’s health research and treatment.

The $110 million gift comes from Houston-based The Brockman Medical Research Foundation, which supports education and research in the science, medicine and healthcare fields. In response, Houston Methodist announced that it will name its forthcoming 26-story hospital facility the Brockman Centennial Tower.

The tower’s entrance will be named the Anna Margaret Bellows Centennial Hall to honor Anna Margaret Bellows, a young camper who died during the Camp Mystic flooding last summer.

“This extraordinary gift accelerates discovery and transforms how care is delivered,” Dr. Marc Boom, president and CEO of Houston Methodist, said in a news release. “We are grateful to The Brockman Medical Research Foundation for its incredible generosity and vision that will help change the lives of generations of patients. Naming Centennial Tower in recognition of this gift reflects the scale of this commitment and its impact on the future of neuroscience, neurological care and women’s health.”

The gift will be divided into two parts:

  • $100 million will go toward creating an innovation fund within the Houston Methodist Academic Institute and the Houston Methodist Neurological Institute
  • $10 million will be devoted to Houston Methodist's Department of Obstetrics and Gynecology

“This tremendous gift will accelerate translational research that broadens our understanding of neurological and other diseases,” Dr. Jenny Chang, president and CEO of the Houston Methodist Academic Institute, added in the release. “It will allow us to leverage state-of-the-art platforms to detect, diagnose and deliver therapeutics, keeping patient care at the center of our mission.”

The Brockman Centennial Tower is expected to open next year in the Texas Medical Center. Spanning more than 1 million square feet, it will house 400 patient beds, an expanded emergency department, new operating rooms and a rooftop garden. It will be connected to Houston Methodist's flagship Paula and Joseph C. “Rusty” Walter III Tower, which opened in 2018. The Centennial Tower was estimated to cost $1.4 billion when announced in 2022.

In addition to the news of the Brockman gift, Houston Methodist also announced this month that it has launched the Houston Methodist Center for Cell and Gene Therapy and tapped an internationally recognized scientist as its leader.

The new center is focused on discovering and developing innovative and cost-effective therapies for a variety of congenital and acquired diseases, including cancer, HIV and cardiovascular disease.

Dr. Malcolm Brenner has been named as the center's inaugural leader and will assume the role starting in October. He will work alongside scientists and support staff from Baylor College of Medicine and Texas Children's Hospital.

Brenner is a professor of pediatrics, medicine, molecular and human genetics and translational biology at Baylor College of Medicine. He is known for making early advances in using bone marrow transplantation as a form of cell therapy and in engineered immune-cell treatments for cancer and infections, according to a release from Houston Methodist.

“Malcolm Brenner is a pioneer in the field of cell and gene therapy and is uniquely qualified to lead Houston Methodist’s research efforts in this field,” Chang added. “His vision and leadership will play a pivotal role in advancing our work in this space.”